258 related articles for article (PubMed ID: 8941212)
21. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
22. Human fetal chromaffin cells: a potential tool for cell pain therapy.
Jozan S; Aziza J; Châtelin S; Evra C; Courtade-Saïdi M; Parant O; Sol JC; Zhou H; Lazorthes Y
Exp Neurol; 2007 Jun; 205(2):525-35. PubMed ID: 17466976
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Kramer K; Gerald W; LeSauteur L; Uri Saragovi H; Cheung NK
Clin Cancer Res; 1996 Aug; 2(8):1361-7. PubMed ID: 9816308
[TBL] [Abstract][Full Text] [Related]
24. Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors.
Cohen PS; Cooper MJ; Helman LJ; Thiele CJ; Seeger RC; Israel MA
Cancer Res; 1990 Sep; 50(18):6055-61. PubMed ID: 2393870
[TBL] [Abstract][Full Text] [Related]
25. Aberrant bcl-2 and bax protein expression related to chemotherapy response in neuroblastoma.
Gallo G; Giarnieri E; Bosco S; Cappelli C; Alderisio M; Giovagnoli MR; Giordano A; Vecchione A
Anticancer Res; 2003; 23(1B):777-84. PubMed ID: 12680183
[TBL] [Abstract][Full Text] [Related]
26. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma.
Hedborg F; Ohlsson R; Sandstedt B; Grimelius L; Hoehner JC; Pählman S
Am J Pathol; 1995 Apr; 146(4):833-47. PubMed ID: 7717451
[TBL] [Abstract][Full Text] [Related]
27. RET expression and neuron-like differentiation of pheochromocytoma and normal chromaffin cells.
Powers JF; Picard KL; Tischler AS
Horm Metab Res; 2009 Sep; 41(9):710-4. PubMed ID: 19551609
[TBL] [Abstract][Full Text] [Related]
28. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
29. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
[TBL] [Abstract][Full Text] [Related]
30. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.
Zhang PJ; Genega EM; Tomaszewski JE; Pasha TL; LiVolsi VA
Mod Pathol; 2003 Jun; 16(6):591-7. PubMed ID: 12808065
[TBL] [Abstract][Full Text] [Related]
31. BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma.
Braaten KM; Betensky RA; de Leval L; Okada Y; Hochberg FH; Louis DN; Harris NL; Batchelor TT
Clin Cancer Res; 2003 Mar; 9(3):1063-9. PubMed ID: 12631608
[TBL] [Abstract][Full Text] [Related]
32. Phox2B mutations and the Delta-Notch pathway in neuroblastoma.
van Limpt V; Chan A; Schramm A; Eggert A; Versteeg R
Cancer Lett; 2005 Oct; 228(1-2):59-63. PubMed ID: 16084642
[TBL] [Abstract][Full Text] [Related]
33. Origin of neuroblastic tumors: clues for future therapeutics.
Mora J; Gerald WL
Expert Rev Mol Diagn; 2004 May; 4(3):293-302. PubMed ID: 15137897
[TBL] [Abstract][Full Text] [Related]
34. [The glial cell in the ontogenesis of the human peripheral sympathetic nervous system and in neuroblastoma].
Magro G; Grasso S
Pathologica; 2001 Oct; 93(5):505-16. PubMed ID: 11725352
[TBL] [Abstract][Full Text] [Related]
35. Implications of prognostic markers in brain tumors.
Grzybicki DM; Moore SA
Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
[TBL] [Abstract][Full Text] [Related]
36. Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression.
Hoehner JC; Hedborg F; Wiklund HJ; Olsen L; Påhlman S
Int J Cancer; 1995 Jul; 62(1):19-24. PubMed ID: 7601561
[TBL] [Abstract][Full Text] [Related]
37. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
38. Histogenesis and differentiation potential of central neurocytomas.
von Deimling A; Kleihues P; Saremaslani P; Yasargil MG; Spoerri O; Südhof TC; Wiestler OD
Lab Invest; 1991 Apr; 64(4):585-91. PubMed ID: 1901927
[TBL] [Abstract][Full Text] [Related]
39. Expression of neuronal markers suggests heterogeneity of chick sympathoadrenal cells prior to invasion of the adrenal anlagen.
Ernsberger U; Esposito L; Partimo S; Huber K; Franke A; Bixby JL; Kalcheim C; Unsicker K
Cell Tissue Res; 2005 Jan; 319(1):1-13. PubMed ID: 15565470
[TBL] [Abstract][Full Text] [Related]
40. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
